Biotech

All Articles

FDA junks adcomm for Applied's uncommon disease medication

.After dismissing the choice date for Applied Rehabs' metabolic problem drug govorestat, the FDA has...

Novo inks $600M NanoVation deal to research hereditary drugs ex-liver

.Novo Nordisk is continuing its own push into genetic medications, consenting to pay NanoVation Ther...

Innovent links cytokine to colon cancer responses

.Innovent Biologics has actually made the case that its gate inhibitor-cytokine blend protein posses...

Merck, Daiichi ADC strikes goal in period 3 lung cancer cells research study

.A period 3 trial of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC)...

Rakovina grows artificial intelligence focus along with collab to choose cancer aim ats

.Five months after Rakovina Rehabs turned towards artificial intelligence, the cancer-focused biotec...

Ascendis' dwarfism drug smash hits in phase 3, intimidates BioMarin

.Ascendis Pharma has actually emerged as a prospective danger to BioMarin's Voxzogo, disclosing peri...

Despite ph. 3 skip, Alkeus views path ahead for eye health condition property

.Though Alkeus Pharmaceuticals' oral eye ailment asset failed to considerably reduce geographical at...

Kairos goes public along with $6M IPO to cash tests of cancer cells medication

.With a trio of biotechs attacking the Nasdaq on Friday, it was easy to overlook a smaller-scale pub...

Vaccine as well as Keytruda combo efficient in squamous cell carcinoma

.Immune gate preventions are actually the superheroes of cancer therapy. Drugs like Bristol Myers Sq...

Cue Biopharma mark time J&ampJ vet as CBO-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of notable management hirings, firings as we...